Caged-carvedilol as a new tool for visible-light photopharmacology of β-adrenoceptors in native tissues

Adrenoceptors are G protein-coupled receptors involved in a large variety of physiological processes, also under pathological conditions. This is due in large part to their ubiquitous expression in the body exerting numerous essential functions. Therefore, the possibility to control their activity w...

Descripción completa

Detalles Bibliográficos
Autores: Durán-Corbera, Anna, Font, Joan, Faria, Melissa, Prats, Eva, Consegal, Marta, Catena, Juan Lorenzo, Muñoz, Lourdes, Raldúa, Demetrio, Rodríguez-Sinovas, Antonio, Llebaria, Amadeu, Rovira, Xavier
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/280895
Acceso en línea:http://hdl.handle.net/10261/280895
https://api.elsevier.com/content/abstract/scopus_id/85138627687
Access Level:acceso abierto
Palabra clave:Pharmacology
Biochemistry
Biological sciences
Biological sciences research methodologies
Cell biology
Medical biochemistry
Descripción
Sumario:Adrenoceptors are G protein-coupled receptors involved in a large variety of physiological processes, also under pathological conditions. This is due in large part to their ubiquitous expression in the body exerting numerous essential functions. Therefore, the possibility to control their activity with high spatial and temporal precision would constitute a valuable research tool. In this study, we present a caged version of the approved non-selective β-adrenoceptor antagonist carvedilol, synthesized by alkylation of its secondary amine with a coumarin derivative. Introducing this photo-removable group abolished carvedilol physiological effects in cell cultures, mouse isolated perfused hearts and living zebrafish larvae. Only after visible light application, carvedilol was released and the different physiological systems were pharmacologically modulated in a similar manner as the control drug. This research provides a new photopharmacological tool for a wide range of research applications that may help in the development of future precise therapies.